EARA voices concerns to UK Parliament on implications of no-deal Brexit
Updated: Dec 13, 2019
Critical to the continuing success of the biomedical sector will be the timely and efficient import/export transport of purpose-bred research animals, biological samples and vaccines.
The submission also offers concrete proposals for avoiding delays in the movement of animals and related materials.
‘Without the ability to move research animals from one country, or continent, to another, or from a breeder or supplier, to a research institution, crucial scientific research to discover new treatments may be disrupted,’ said Kirk Leech, EARA Executive Director.